SD-Nfe2l2em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 70 and 84 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
body mass |
male |
10 days-12 days |
4 |
287.0 |
g |
26.7 |
53.4 |
body weighing method |
0.0 |
0 |
|
100732 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
arterial blood pressure trait |
male |
9 days-11 days |
5 |
97.0 |
mmHg |
2.9 |
6.48 |
vascular fluid filled catheter |
0.0 |
0 |
|
100742 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then calcium-free buffer solution |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
10 days-12 days |
4 |
241.0 |
um |
6.8 |
13.6 |
ex vivo method |
0.0 |
0 |
max dilation |
100744 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
body mass |
male |
9 days-11 days |
6 |
307.0 |
g |
11.5 |
28.17 |
body weighing method |
0.0 |
0 |
|
100736 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
body mass |
male |
9 days-11 days |
4 |
299.0 |
g |
22.2 |
44.4 |
body weighing method |
0.0 |
0 |
|
100734 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
4 |
154.0 |
um |
15.0 |
30.0 |
ex vivo method |
0.0 |
0 |
resting diameter |
100752 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
percent change in middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
4 |
37.4 |
% |
6.53 |
13.06 |
ex vivo method |
0.0 |
0 |
tone |
100758 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
arterial blood pressure trait |
male |
9 days-11 days |
3 |
102.0 |
mmHg |
3.0 |
5.2 |
vascular fluid filled catheter |
0.0 |
0 |
|
100740 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
5 |
243.0 |
um |
7.0 |
15.65 |
ex vivo method |
0.0 |
0 |
max dilation |
100748 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
percent change in middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
10 days-12 days |
4 |
53.9 |
% |
3.29 |
6.58 |
ex vivo method |
0.0 |
0 |
tone |
100756 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
4 |
248.0 |
um |
9.0 |
18.0 |
ex vivo method |
0.0 |
0 |
max dilation |
100746 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
10 days-12 days |
4 |
111.0 |
um |
6.0 |
12.0 |
ex vivo method |
0.0 |
0 |
resting diameter |
100750 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
5 |
136.0 |
um |
10.2 |
22.81 |
ex vivo method |
0.0 |
0 |
resting diameter |
100754 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
percent change in middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
5 |
43.9 |
% |
4.99 |
11.16 |
ex vivo method |
0.0 |
0 |
tone |
100760 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 70 and 84 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
arterial blood pressure trait |
male |
10 days-12 days |
4 |
95.0 |
mmHg |
2.6 |
5.2 |
vascular fluid filled catheter |
0.0 |
0 |
|
100738 |
2520 |